1. Is Sharda Cropchem Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Sharda Cropchem Ltd is a good quality company.
2. Is Sharda Cropchem Ltd undervalued or overvalued?
The key valuation ratios of Sharda Cropchem Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
3. Is Sharda Cropchem Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sharda Cropchem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||14.8%||15.1%||18.3%||24.9%||23.9%||19.4%||13.1%||19.7%||14.5%||18.2%||-|
|Value Creation Index ⓘ||0.1||0.1||0.3||0.8||0.7||0.4||-0.1||0.4||0.0||0.3||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||-2.5%||42.3%||21.5%||20.8%||30.2%||9.1%||0.8%||25.8%||45%||-|
|Adj EPS ⓘ||7||7.7||11||18.3||20.9||21.8||16||26||22||32.6||22.4|
|YoY Gr. Rt. %||-||10.8%||42.8%||65.9%||14.6%||4.1%||-26.6%||62.6%||-15.3%||48.1%||-|
|BVPS (₹) ⓘ||50.1||57.3||65.1||81.7||98.6||118.1||130||145.3||166.6||191.9||189.1|
|Adj Net Profit ⓘ||62.8||69.5||99.3||165||189||196||144||234||199||294||202|
|Cash Flow from Ops. ⓘ||122||143||14.2||142||123||-14.6||513||53||202||277||-|
|Debt/CF from Ops. ⓘ||0||0||2.7||0||0||-11.6||0||0||0.3||0.1||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||18.7%||9.3%||26.9%||48.1%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||14.9||14.4||18||24.9||23.2||20.1||12.9||18.9||14.1||18.2||11.7|
|Op. Profit Mgn % ⓘ||22||24.5||21.9||25.4||24.7||24.1||20.1||18.2||18.3||21||18.3|
|Net Profit Mgn % ⓘ||11.3||12.9||12.9||17.6||16.7||13.4||9||14.5||9.8||10||6.7|
|Debt to Equity ⓘ||0||0||0.1||0||0||0.2||0||0||0.1||0||-|
|Working Cap Days ⓘ||284||276||249||304||336||358||361||363||347||306||0|
|Cash Conv. Cycle ⓘ||112||80||76||74||72||125||92||93||100||98||0|
Sales growth is growing at healthy rate in last 3 years 22.48%
Net Profit is growing at healthy rate in last 3 years 26.85%
Sales growth is good in last 4 quarters at 39.09%
Return on Equity has declined versus last 3 years average to 11.70%
|TTM EPS (₹)||22.4||37|
|TTM Sales (₹ Cr.)||3,006||3,782|
|BVPS (₹.) ⓘ||189.1||214.5|
|Reserves (₹ Cr.) ⓘ||1,616||1,845|
|From the Market|
|52 Week Low / High (₹)||299.00 / 767.70|
|All Time Low / High (₹)||99.00 / 767.70|
|Market Cap (₹ Cr.)||4,042|
|Equity (₹ Cr.)||90.2|
|Face Value (₹)||10|
|Industry PE ⓘ||33.7|
Sharda Cropchem was incorporated as Sharda Worldwide Exports on March 12, 2004, in Mumbai, as a private limited company under the Companies Act, 1956. Initially the company began its operations through two sole proprietary firms, each set up by Ramprakash V. Bubna and Sharda R. Bubna. After incorporation as Sharda Worldwide Exports in 2004, the generic agrochemical business and non-agrochemical business conducted by both firms were transferred to the company. The company was converted into a public limited company and changed its name to Sharda Cropchem on September 18, 2013.
Sharda Cropchem is a crop protection chemical company engaged in the marketing and distribution of a wide range of formulations and generic active ingredients globally. It is also involved in order based procurement and supply of Belts, general chemicals, dyes and dye intermediates. It procures these non-agrochemical products, primarily, from the manufacturers in China or India and supplies them in over 35 countries across Australia, Asia, Europe, North America and Latin America. The company has recently entered into the biocide segment and has acquired several registrations from the existing registration holders, primarily, in Europe.
As of August 5, 2014, the company had over 180 Good Laboratory Practices (GLP) certified dossiers and as of July 15, 2014, it owned over 1,040 registrations for formulations and over 155 registrations for generic active ingredients across Europe, NAFTA, Latin America and Rest of the World.
The companyâ€™s library of dossiers gives it a competitive edge and facilitates in seeking registrations in different countries in a time efficient manner. This also fosters its ability to operate in and distribute diversified range of formulations and generic active ingredients globally including highly regulated markets, which would not be permitted without such registrations. As of August 5, 2014, it has filed over 500 applications for seeking registrations globally which are pending at different stages.
Milestones: In November 2011, the company acquired 76% stake in Axis Crop Science, which is a company focused on marketing and distribution of formulations in India.